Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
2021 · Scientific Reports · 52 citations
https://doi.org/10.1038/s41598-021-99827-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
241
Citations
4
h-index
4
i10-index
Alice Fermeglia is an academic researcher from University of Trieste. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & DNA Repair Mechanisms & PARP inhibition in cancer therapy. The author has an h-index of 4, co-authored 8 publications.
Click to start Chat